Cantor Fitzgerald reissued their overweight rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $5.00 price target on the stock.
Separately, Needham & Company LLC restated a buy rating and issued a $7.00 price target on shares of DocGo in a research note on Thursday, August 8th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of Buy and an average price target of $6.10.
Check Out Our Latest Report on DocGo
DocGo Price Performance
DocGo (NASDAQ:DCGO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). DocGo had a net margin of 3.97% and a return on equity of 8.90%. The business had revenue of $164.95 million for the quarter, compared to analysts’ expectations of $166.61 million. Analysts expect that DocGo will post 0.23 EPS for the current fiscal year.
Hedge Funds Weigh In On DocGo
Institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Asset Management L.P. increased its holdings in shares of DocGo by 1,655.7% in the second quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock worth $361,000 after purchasing an additional 110,189 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares during the period. Marathon Capital Management boosted its position in shares of DocGo by 2.3% during the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after buying an additional 6,285 shares during the period. Deerfield Management Company L.P. Series C boosted its holdings in shares of DocGo by 41.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after purchasing an additional 2,091,569 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in shares of DocGo by 58.5% in the second quarter. AQR Capital Management LLC now owns 344,963 shares of the company’s stock valued at $1,066,000 after purchasing an additional 127,320 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
See Also
- Five stocks we like better than DocGo
- What Are Dividends? Buy the Best Dividend Stocks
- The Average 401k Balance by Age Explained
- What are earnings reports?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What is the FTSE 100 index?
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.